Federal Univesity of Rio Grande do Norte
Rio Grande Do Norte, Natal, 59072-970, Brazil
NCT Number: NCT01972100
The study hypothesis is a improved muscle fatigue resistance induced by low-level laser therapy applied between sets of intense exercises.
Looking for future studies?
Notify Me18 year–28 year
Male
Interventional
Not applicable
Rio Grande Do Norte, Natal, 59072-970, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of low-level laser therapy(LLLT)or placebo-LLLT applied on quadriceps femoris muscles between sets of isokinetic knee flexion-extension exercise
Other names: Low-level laser therapy;, Placebo low-level laser theraphy, Laser device (808nm; 100mW; DMC®, Brazil).
Other names: Isokinetic knee flexion-extension exercise
Time frame: 1 week
Evaluation of maximum repetitions of knee flexion-extension in isokinetic dynamometer. Volunteers were assessed on Monday (pre evaluation - baseline), on Wednesday performed a session of exercises and on Friday were assessed again (final evaluation).
Time frame: 1 week
Evaluation of median frequency by surface electromyography of quadriceps femoris muscles during maximum repetitions of knee flexion-extension in isokinetic dynamometer. Volunteers were assessed on Monday (pre evaluation - baseline), on Wednesday performed a session of exercises and on Friday were assessed again (final evaluation).
Cleber Ferraresi
Other
Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance: a Randomized Double-blind Crossover Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details